Fortimicins A and B, new aminoglycoside antibiotics. III. Structural identification. 1977

R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher

The structures of fortimicins A and B have been determined by PMR, CMR, mass spectra and CD combined with chemical degradations. Both antibiotics are pseudodisaccharides and incorporate a novel aminocyclitol, fortamine. In contrast to the diaminocyclitol moieties of known aminoglycosides, fortamine is a 1,4-diamine, contains both N- and O-methyl groups and possesses chiro stereochemistry. Both antibiotics are glycosides of 6-epi-purpurosamine B, but fortimicin A differs from fortimicin B by being a glycyl amide.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
July 1977, The Journal of antibiotics,
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
September 1979, The Journal of antibiotics,
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
July 1977, The Journal of antibiotics,
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
July 1977, The Journal of antibiotics,
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
September 1979, The Journal of antibiotics,
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
October 1979, The Journal of antibiotics,
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
January 1983, Molecular pharmacology,
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
February 1981, The Journal of antibiotics,
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
September 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
R S Egan, and R S Stanaszek, and M Cirovic, and S L Mueller, and J Tadanier, and J R Martin, and P Collum, and A W Goldstein, and R L De Vault, and A C Sinclair, and E E Fager, and L A Mitscher
October 2010, Expert opinion on therapeutic patents,
Copied contents to your clipboard!